United Bio-Medtech Announces Board Resolution for Second Treasury Stock Buyback
United Bio-Medtech's board of directors resolved on May 6, 2026, to implement a second treasury stock buyback program, planning to repurchase 1.5 million common shares with an upper limit of NT$5.461 billion, primarily for transfer to employees.
📋 Article Processing Timeline
- 📰 Published: May 6, 2026 at 09:00
- 🔍 Collected: May 7, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 7, 2026 at 08:16 (16 min after Collected)
1. Date of Board Resolution: 05/06/115 (2026/05/06)
2. Purpose of Share Repurchase: Transfer of shares to employees.
3. Type of Shares to be Repurchased: Common stock.
4. Upper Limit of Total Amount for Share Repurchase (in NT$): 5,461,571,281
5. Scheduled Repurchase Period: 05/07/115 ~ 07/05/115 (2026/05/07 ~ 2026/07/05)
6. Scheduled Quantity to be Repurchased (shares): 1,500,000
7. Repurchase Price Range (NT$): 30.00~46.00. If the company's stock price falls below the lower limit of the range, buybacks will continue.
8. Method of Repurchase: Through the centralized trading market.
9. Percentage of Repurchased Shares to Company's Total Issued Shares (%): 0.77
10. Cumulative Number of Company Shares Held as of Declaration (shares): 0
11. Share Repurchases in the Past Five Years as of Declaration:
None.
12. Status of Declared but Unexecuted Repurchases:
Not applicable.
13. Minutes of Board Resolution for Share Repurchase:
The 21st meeting of the 7th Board of Directors resolved to repurchase common stock of the company from the centralized trading market, with a total amount not exceeding NT$69,000 thousand, at a price range between NT$30 and NT$46 per share, for a planned repurchase of 1,500,000 shares.
14. Transfer Method as Stipulated by "Regulations Governing Share Repurchases by Listed and OTC Companies", Article 10:
United Bio-Medtech Investment Holding Co., Ltd.
Employee Share Transfer Method for Repurchased Shares
Article 1: To motivate employee morale and enhance employee loyalty, in accordance with Article 28-2, Paragraph 1, Item 1 of the Securities Transaction Act and the "Regulations Governing Share Repurchases by Listed and OTC Companies" issued by the Financial Supervisory Commission, this company has established this method for the transfer of repurchased shares to employees. The transfer of repurchased shares to employees shall be handled in accordance with these regulations, in addition to relevant laws and regulations.
(Type of Shares Transferred, Rights Content, and Restrictions on Rights)
Article 2: The shares to be transferred to employees are common shares. Their rights and obligations shall be the same as other circulating common shares, except as otherwise stipulated by relevant laws and regulations and this method.
(Transfer Period)
Article 3: The repurchased shares may be transferred to employees, in one or multiple tranches, within five years from the date of repurchase, in accordance with the provisions of this method.
(Eligibility of Recipients)
Article 4: The recipients of the share transfer are employees who are still employed (including personnel from domestic and overseas subsidiaries that directly or indirectly hold more than 50% of the voting shares of the same invested company) as of the employee stock option grant date, and are eligible to subscribe according to the subscription amount stipulated in Article 5 of this method. Employees who resign (or take unpaid leave) between the employee stock option grant date and the payment deadline shall forfeit their subscription eligibility. Part-time employees, temporary workers, short-term interns, and contract workers are not applicable to this method.
(Employee Subscription Quantity)
Article 5: This company determines the number of shares employees may subscribe to based on standards such as employee rank, years of service, and special contributions to the company, while also considering the total number of repurchased shares held by the company on the grant date and the upper limit for a single employee's subscription quantity. The actual specific subscription eligibility and quantity shall be determined by the Board of Directors and shall not be authorized to the Chairman. Furthermore, the company shall specify relevant review procedures in accordance with the applicability of Attachment 1.
Employees who fail to make payment by the subscription payment deadline shall be deemed to have waived their rights. The remaining unsubscribed shares may be offered to other employees as resolved by the Board of Directors.
(Procedure for Conversion)
Article 6: The procedure for transferring repurchased shares to employees is as follows:
1. Announce, report, and repurchase the company's shares within the execution period, in accordance with the Board of Directors' resolution.
2. The Board of Directors shall set and announce the employee stock option grant date, subscription quantity standards, payment period, rights content, and restrictive conditions according to this method.
3. Tally the actual subscribed and paid-up shares and proceed with the share transfer and registration of ownership.
(Agreed Share Transfer Price)
Article 7: The transfer price for the repurchased shares to employees shall be the average repurchase price. However, if the company's issued common shares increase before the transfer, it may be adjusted within the scope of the increase ratio. Alternatively, if the shares are transferred to employees at a price lower than the average repurchase price, in accordance with the company's articles of incorporation, it shall be submitted to the most recent shareholders' meeting for approval by shareholders representing more than half of the total issued shares, with two-thirds or more of the voting rights of the attending shareholders agreeing. The notice of the shareholders' meeting must include the "Matters as stipulated in Article 10-1 of the "Regulations Governing Share Repurchases by Listed and OTC Companies"" for explanation before proceeding.
(Rights and Obligations After Transfer)
Article 8: After the repurchased shares are transferred to employees and the ownership registration is completed, all rights and obligations shall be the same as the original shares, unless otherwise stipulated.
Article 9: This method shall take effect upon resolution by the Board of Directors and may be revised by resolution of the Board of Directors.
15. Conversion or Subscription Method as Stipulated by "Regulations Governing Share Repurchases by Listed and OTC Companies", Article 11:
Not applicable.
16. Declaration by the Board of Directors Considering the Company's Financial Condition, Not Affecting Capital Maintenance:
The total number of shares to be repurchased accounts for only 0.77% of the company's issued shares, and the upper limit of the amount required for the repurchase accounts for only 1.38% of the company's current assets. It is hereby declared that the company's Board of Directors has considered the company's financial condition, and the repurchase of these shares does not affect the maintenance of the company's capital.
17. Opinion from Accountant or Securities Underwriter on the Reasonableness of the Share Repurchase Price:
In summary, the decision-making process for the price range set for United Bio-Medtech's share repurchase is legal, the determination of the price range and its impact on the company's financial condition are within a reasonable range, and there are no significant abnormal circumstances.
18. Other Matters Stipulated by the Securities and Futures Bureau:
None.
Keywords: Material Information
2. Purpose of Share Repurchase: Transfer of shares to employees.
3. Type of Shares to be Repurchased: Common stock.
4. Upper Limit of Total Amount for Share Repurchase (in NT$): 5,461,571,281
5. Scheduled Repurchase Period: 05/07/115 ~ 07/05/115 (2026/05/07 ~ 2026/07/05)
6. Scheduled Quantity to be Repurchased (shares): 1,500,000
7. Repurchase Price Range (NT$): 30.00~46.00. If the company's stock price falls below the lower limit of the range, buybacks will continue.
8. Method of Repurchase: Through the centralized trading market.
9. Percentage of Repurchased Shares to Company's Total Issued Shares (%): 0.77
10. Cumulative Number of Company Shares Held as of Declaration (shares): 0
11. Share Repurchases in the Past Five Years as of Declaration:
None.
12. Status of Declared but Unexecuted Repurchases:
Not applicable.
13. Minutes of Board Resolution for Share Repurchase:
The 21st meeting of the 7th Board of Directors resolved to repurchase common stock of the company from the centralized trading market, with a total amount not exceeding NT$69,000 thousand, at a price range between NT$30 and NT$46 per share, for a planned repurchase of 1,500,000 shares.
14. Transfer Method as Stipulated by "Regulations Governing Share Repurchases by Listed and OTC Companies", Article 10:
United Bio-Medtech Investment Holding Co., Ltd.
Employee Share Transfer Method for Repurchased Shares
Article 1: To motivate employee morale and enhance employee loyalty, in accordance with Article 28-2, Paragraph 1, Item 1 of the Securities Transaction Act and the "Regulations Governing Share Repurchases by Listed and OTC Companies" issued by the Financial Supervisory Commission, this company has established this method for the transfer of repurchased shares to employees. The transfer of repurchased shares to employees shall be handled in accordance with these regulations, in addition to relevant laws and regulations.
(Type of Shares Transferred, Rights Content, and Restrictions on Rights)
Article 2: The shares to be transferred to employees are common shares. Their rights and obligations shall be the same as other circulating common shares, except as otherwise stipulated by relevant laws and regulations and this method.
(Transfer Period)
Article 3: The repurchased shares may be transferred to employees, in one or multiple tranches, within five years from the date of repurchase, in accordance with the provisions of this method.
(Eligibility of Recipients)
Article 4: The recipients of the share transfer are employees who are still employed (including personnel from domestic and overseas subsidiaries that directly or indirectly hold more than 50% of the voting shares of the same invested company) as of the employee stock option grant date, and are eligible to subscribe according to the subscription amount stipulated in Article 5 of this method. Employees who resign (or take unpaid leave) between the employee stock option grant date and the payment deadline shall forfeit their subscription eligibility. Part-time employees, temporary workers, short-term interns, and contract workers are not applicable to this method.
(Employee Subscription Quantity)
Article 5: This company determines the number of shares employees may subscribe to based on standards such as employee rank, years of service, and special contributions to the company, while also considering the total number of repurchased shares held by the company on the grant date and the upper limit for a single employee's subscription quantity. The actual specific subscription eligibility and quantity shall be determined by the Board of Directors and shall not be authorized to the Chairman. Furthermore, the company shall specify relevant review procedures in accordance with the applicability of Attachment 1.
Employees who fail to make payment by the subscription payment deadline shall be deemed to have waived their rights. The remaining unsubscribed shares may be offered to other employees as resolved by the Board of Directors.
(Procedure for Conversion)
Article 6: The procedure for transferring repurchased shares to employees is as follows:
1. Announce, report, and repurchase the company's shares within the execution period, in accordance with the Board of Directors' resolution.
2. The Board of Directors shall set and announce the employee stock option grant date, subscription quantity standards, payment period, rights content, and restrictive conditions according to this method.
3. Tally the actual subscribed and paid-up shares and proceed with the share transfer and registration of ownership.
(Agreed Share Transfer Price)
Article 7: The transfer price for the repurchased shares to employees shall be the average repurchase price. However, if the company's issued common shares increase before the transfer, it may be adjusted within the scope of the increase ratio. Alternatively, if the shares are transferred to employees at a price lower than the average repurchase price, in accordance with the company's articles of incorporation, it shall be submitted to the most recent shareholders' meeting for approval by shareholders representing more than half of the total issued shares, with two-thirds or more of the voting rights of the attending shareholders agreeing. The notice of the shareholders' meeting must include the "Matters as stipulated in Article 10-1 of the "Regulations Governing Share Repurchases by Listed and OTC Companies"" for explanation before proceeding.
(Rights and Obligations After Transfer)
Article 8: After the repurchased shares are transferred to employees and the ownership registration is completed, all rights and obligations shall be the same as the original shares, unless otherwise stipulated.
Article 9: This method shall take effect upon resolution by the Board of Directors and may be revised by resolution of the Board of Directors.
15. Conversion or Subscription Method as Stipulated by "Regulations Governing Share Repurchases by Listed and OTC Companies", Article 11:
Not applicable.
16. Declaration by the Board of Directors Considering the Company's Financial Condition, Not Affecting Capital Maintenance:
The total number of shares to be repurchased accounts for only 0.77% of the company's issued shares, and the upper limit of the amount required for the repurchase accounts for only 1.38% of the company's current assets. It is hereby declared that the company's Board of Directors has considered the company's financial condition, and the repurchase of these shares does not affect the maintenance of the company's capital.
17. Opinion from Accountant or Securities Underwriter on the Reasonableness of the Share Repurchase Price:
In summary, the decision-making process for the price range set for United Bio-Medtech's share repurchase is legal, the determination of the price range and its impact on the company's financial condition are within a reasonable range, and there are no significant abnormal circumstances.
18. Other Matters Stipulated by the Securities and Futures Bureau:
None.
Keywords: Material Information